Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Platelet glycoprotein IIb/IIIa inhibitors: recognition of a two-edged sword?

× No keyword cloud information.

21 in total

Review 1. Inflammation and atherosclerosis.

Authors: Mehdi H Shishehbor; Deepak L Bhatt
Journal: Curr Atheroscler Rep Date: 2004-03 Impact factor: 5.113

Review 2. Comparative pharmacology of GP IIb/IIIa antagonists.

Authors: Karsten Schrör; Artur-Aron Weber
Journal: J Thromb Thrombolysis Date: 2003-04 Impact factor: 2.300

3. Determining the efficacy of antiplatelet therapies for the individual: lessons from clinical trials.

Authors: Steven R Steinhubl; David J Schneider; Peter B Berger; Richard C Becker
Journal: J Thromb Thrombolysis Date: 2007-11-01 Impact factor: 2.300

Review 4. Antiplatelet treatment in stable coronary artery disease.

Authors: Charles J Knight
Journal: Heart Date: 2003-10 Impact factor: 5.994

5. The use of the point of care Helena ICHOR/Plateletworks and the Accumetrics Ultegra RPFA for assessment of platelet function with GPIIB-IIIa antagonists.

Authors: Melanie M White; Rajini Krishnan; Teddi J Kueter; Mary V Jacoski; Lisa K Jennings
Journal: J Thromb Thrombolysis Date: 2004-12 Impact factor: 2.300

Review 6. The GPIIb/IIIa (integrin alphaIIbbeta3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend.

Authors: Barry S Coller; Sanford J Shattil
Journal: Blood Date: 2008-10-15 Impact factor: 22.113

7. PROBING αIIbβ3: LIGAND INTERACTIONS BY DYNAMIC FORCE SPECTROSCOPY AND SURFACE PLASMON RESONANCE.

Authors: Roy R Hantgan; Martin Guthold; Samrat Dutta; David A Horita
Journal: Nano Life Date: 2013

Review 8. Integrin αIIbβ3: from discovery to efficacious therapeutic target.

Authors: Kamila Bledzka; Susan S Smyth; Edward F Plow
Journal: Circ Res Date: 2013-04-12 Impact factor: 17.367

9. Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury.

Authors: Mohd Hafeez Faridi; Mehmet M Altintas; Camilo Gomez; Juan Camilo Duque; Roberto I Vazquez-Padron; Vineet Gupta
Journal: Biochim Biophys Acta Date: 2013-02-26

Review 10. Leukocyte integrins and their ligand interactions.

Authors: Young-Min Hyun; Craig T Lefort; Minsoo Kim
Journal: Immunol Res Date: 2009-01-29 Impact factor: 2.829